BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12210482)

  • 1. Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system.
    Zhang S; Zeng G; Kao C; Gardner T; Sweeney C; Yang NS; Eble JN; Cheng L
    Prostate; 2002 Sep; 53(1):69-76. PubMed ID: 12210482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells transfected with interleukin-12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo.
    Zhang S; Zeng G; Wilkes DS; Reed GE; McGarry RC; Eble JN; Cheng L
    Prostate; 2003 Jun; 55(4):292-8. PubMed ID: 12712408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
    Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.
    Rensing-Ehl A; Frei K; Flury R; Matiba B; Mariani SM; Weller M; Aebischer P; Krammer PH; Fontana A
    Eur J Immunol; 1995 Aug; 25(8):2253-8. PubMed ID: 7545115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
    Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
    Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
    Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
    Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC
    Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
    Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
    Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.
    Lafleur EA; Jia SF; Worth LL; Zhou Z; Owen-Schaub LB; Kleinerman ES
    Cancer Res; 2001 May; 61(10):4066-71. PubMed ID: 11358827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary apoptosis of spiral ganglion cells induced by aminoglycoside: Fas-Fas ligand signaling pathway.
    Bae WY; Kim LS; Hur DY; Jeong SW; Kim JR
    Laryngoscope; 2008 Sep; 118(9):1659-68. PubMed ID: 18758324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand-expressing tumors induce tumor-specific protective immunity in the inoculated hosts but vaccination with the apoptotic tumors suppresses antitumor immunity.
    Tada Y; O-Wang J; Wada A; Takiguchi Y; Tatsumi K; Kuriyama T; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Feb; 10(2):134-40. PubMed ID: 12536202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells.
    Zhang J; Xu G
    Cancer Genet Cytogenet; 2007 Dec; 179(2):112-7. PubMed ID: 18036397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury.
    Yu WR; Liu T; Fehlings TK; Fehlings MG
    Eur J Neurosci; 2009 Jan; 29(1):114-31. PubMed ID: 19120440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1beta sensitizes rat intervertebral disc cells to Fas ligand mediated apoptosis in vitro.
    Cui LY; Liu SL; Ding Y; Huang DS; Ma RF; Huang WG; Hu BS; Pan QH
    Acta Pharmacol Sin; 2007 Oct; 28(10):1671-6. PubMed ID: 17883956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Fas antibody-induced apoptosis and its signal transduction in human gastric carcinoma cell lines.
    Adachi K; Osaki M; Kase S; Takeda A; Ito H
    Int J Oncol; 2003 Sep; 23(3):713-9. PubMed ID: 12888908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
    Kang YH; Lee KA; Ryu CJ; Lee HG; Lim JS; Park SN; Paik SG; Yoon DY
    Cancer Lett; 2006 Jun; 237(1):33-44. PubMed ID: 16019139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells.
    Tada Y; O-Wang J; Seimiya M; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
    Anticancer Res; 2002; 22(2A):831-6. PubMed ID: 12014659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.